eli lilly glp 1 program is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating FDA approves Foundayo, Eli Lilly's

Sergey Terushkin, MD, FACS Compassionate, affordable care for lasting weight loss

The best evidence available is that BPC-157 results in improved outcomes in muscle, tendon, ligament, and bone injury models in animals. There are probably trials ongoing, but if we are being honest about the totality of evidence available to us right now , it is irresponsible to claim either way that BPC-157 does or does not increase performance

This is the question that separates realistic expectations from disappointment

noter : En plus des bienfaits du glutathion au niveau de la protection de lorganisme, ce compos intervient aussi dans la synthse de lADN et des protines

(FYI, the offer of $199 per month for the first two months is only valid for the 0.25 and 0.5 mg doses of Wegovy and is only available until March 31, 2026.) Another option is to ask your healthcare provider if another weight loss medication could be a good fit for you